# Cai Weiliang

> Cai Weiliang is a venture - series unknown investor at Cowin Capital backing Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cowin Capital](https://shizune.co/investors/profile/cowin-capital)
- Total investments: 1
- Last investment: Jul 2022
- Lead investor: 0%
- Last updated: Aug 2026

Cai Weiliang is a partner at Cowin Capital. Prior to that, Cai served as the Head of Investment Banking and General Manager of Private Equity (Greater China) at OCBC Bank.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Biotechnology | 1 | 100% |
| Manufacturing | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Innogen Pharmaceutical | Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company. |  | Venture - Series Unknown | Jul 19, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Boyuan Capital](https://shizune.co/investors/profile/boyuan-capital-4fca) — VC Fund, 1 deal together
- [Hongtai Fund](https://shizune.co/investors/profile/hongtai-fund) — VC Fund, 1 deal together
- [Korea Investment Partners](https://shizune.co/investors/profile/korea-investment-partners) — VC Fund, 1 deal together
- [Lanting Capital](https://shizune.co/investors/profile/lanting-capital) — VC Fund, 1 deal together

## About Cowin Capital

VC Fund · Shenzhen, China

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

5 contacts available at Cowin Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Cai Weiliang | Partner | https://shizune.co/investors/profile/cai-weiliang |
| Ding Baoyu | Managing Director, Partner | https://shizune.co/investors/profile/ding-baoyu |
| Dong Dongdong | Partner | https://shizune.co/investors/profile/dong-dongdong |
| Dong Ming | Hangzhou Area Partner | https://shizune.co/investors/profile/dong-ming |
| Huang Li | Founding Partner & CEO | https://shizune.co/investors/profile/huang-li |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Cai Weiliang invest in?

Cai Weiliang invests primarily in Biopharma, Biotechnology and Manufacturing startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cai Weiliang last invest?

The most recent investment recorded for Cai Weiliang closed in Jul 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co